Literature DB >> 31161331

High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure.

Meng-Si Luo1, Guan-Jiang Huang2, Lun Wu3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31161331     DOI： 10.1007/s00134-019-05652-8

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  3 in total

1.  Evidence based medicine (EBM) in practice: applying relative risk and relative risk reduction.

Authors:  Philip Schoenfeld
Journal:  Am J Gastroenterol       Date:  2004-11       Impact factor: 10.864

Review 2.  High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: a systematic review and meta-analysis.

Authors:  B Rochwerg; D Granton; D X Wang; Y Helviz; S Einav; J P Frat; A Mekontso-Dessap; A Schreiber; E Azoulay; A Mercat; A Demoule; V Lemiale; A Pesenti; E D Riviello; T Mauri; J Mancebo; L Brochard; K Burns
Journal:  Intensive Care Med       Date:  2019-03-19       Impact factor: 17.440

3.  Stress ulcer prophylaxis with proton pump inhibitors or histamin-2 receptor antagonists in adult intensive care patients: a systematic review with meta-analysis and trial sequential analysis.

Authors:  Marija Barbateskovic; Søren Marker; Anders Granholm; Carl Thomas Anthon; Mette Krag; Janus Christian Jakobsen; Anders Perner; Jørn Wetterslev; Morten Hylander Møller
Journal:  Intensive Care Med       Date:  2019-01-24       Impact factor: 17.440
  3 in total
  2 in total

1.  High-flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: author's reply.

Authors:  Bram Rochwerg; D Granton; D X Wang; S Einav; K E A Burns
Journal:  Intensive Care Med       Date:  2019-06-24       Impact factor: 17.440

Review 2.  Promises and challenges of personalized medicine to guide ARDS therapy.

Authors:  Katherine D Wick; Daniel F McAuley; Joseph E Levitt; Jeremy R Beitler; Djillali Annane; Elisabeth D Riviello; Carolyn S Calfee; Michael A Matthay
Journal:  Crit Care       Date:  2021-11-23       Impact factor: 19.334
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.